International Journal of Cardiology. Cardiovascular Risk and Prevention
Overview
International Journal of Cardiology. Cardiovascular Risk and Prevention is a scientific journal, published since 2021 in English. The journal's country of origin is Netherlands and its primary focus area is cardiology & vascular diseases.
Details
Details
Abbr.
Int J Cardiol Cardiovasc Risk Prev
Start
2021
End
Continuing
Frequency
Quarterly
e-ISSN
2772-4875
Country
Netherlands
Language
English
Specialty
Cardiology & Vascular Diseases
Metrics
Metrics
h-index / Ranks: 14180
11
SJR / Ranks: 8067
560
CiteScore / Ranks: 8993
2.80
Recent Articles
1.
Goyal A, Saeed H, Singh A, Abdullah , Sultan W, Amin Z, et al.
Int J Cardiol Cardiovasc Risk Prev
. 2025 Mar;
24:200378.
PMID: 40083536
Introduction: By 2019, nearly 20 million people worldwide had hypertensive heart disease (HHD), resulting in over 1.1 million deaths and 21.5 million disability-adjusted life years (DALYs). Hypertension is a significant...
2.
Ali E, Rahman H, Kamal U, Ali Fahim M, Salman M, Salman A, et al.
Int J Cardiol Cardiovasc Risk Prev
. 2025 Mar;
24:200377.
PMID: 40034236
Introduction: Lung cancer remains the leading cause of cancer-related mortality in the United States and shares cardiovascular risk factors with chronic ischemic heart disease (CIHD). However, the cumulative mortality burden...
3.
Akhtar M, Ashraf D, Nadeem M, Maryam A, Ahmed H, Akhtar M, et al.
Int J Cardiol Cardiovasc Risk Prev
. 2025 Mar;
24:200374.
PMID: 40026602
Background: Atherosclerotic heart disease (ASHD) remains a leading cause of mortality worldwide, especially among older adults. Understanding the long-term mortality trends in ASHD can guide public health strategies and address...
4.
Toledo J
Int J Cardiol Cardiovasc Risk Prev
. 2025 Feb;
24:200375.
PMID: 40007582
The study "E-cigarette use among adolescents in Latin America" reveals a high prevalence of e-cigarette use among teenagers, with a pooled mean of 18.9 %. This highlights the misconception that...
5.
Toledo J
Int J Cardiol Cardiovasc Risk Prev
. 2025 Feb;
24:200373.
PMID: 40007581
No abstract available.
6.
Wu J, Huang D, Li J, Yi J, Lei Y, Yin J
Int J Cardiol Cardiovasc Risk Prev
. 2025 Feb;
24:200372.
PMID: 39995422
Background: Cardiovascular disease (CVD) is a leading cause of death globally, with its incidence and mortality rates continuing to rise. While commonly used biomarkers such as low-density lipoprotein cholesterol (LDL-C),...
7.
Saeed H, Majeed U, Iqbal M, Shahid S, Hussain A, Iftikhar H, et al.
Int J Cardiol Cardiovasc Risk Prev
. 2025 Feb;
24:200371.
PMID: 39925345
Background: Cancer patients are at an increased risk for the incidence and complications of acute myocardial infarction (AMI) due to shared risk factors and treatment-related adverse effects. Mortality trends for...
8.
Ferreira Santos J, Castela I, Gamboa Madeira S, Furtado S, Vieira Pereira H, Teixeira D, et al.
Int J Cardiol Cardiovasc Risk Prev
. 2025 Feb;
24:200368.
PMID: 39897346
Aims: Cardiovascular diseases remain the leading cause of death worldwide. Risk stratification and early interventions are essential to overcome this reality. The aimed to evaluate the prevalence of self-reported cardiovascular...
9.
Leow R, Li T, Chan M, Kong W, Poh K, Kuntjoro I, et al.
Int J Cardiol Cardiovasc Risk Prev
. 2025 Jan;
24:200366.
PMID: 39882191
Introduction: The severity of mitral stenosis (MS) is commonly assessed using mitral valve area (MVA) measured with transthoracic echocardiography (TTE). The dimensionless index (DI) of mitral valve (MV) was recently...
10.
Shuja M, Shakil F, Ali S, Uddin Q, Noman A, Iqbal J, et al.
Int J Cardiol Cardiovasc Risk Prev
. 2025 Jan;
24:200370.
PMID: 39877074
Background: Previous studies suggest similar cardiovascular (CV) benefits for either percutaneous coronary intervention (PCI) or coronary artery bypass graft (CABG) in patients with left main coronary artery disease (LMCAD). However,...